Search Results - "Fabritiis, P. De"

Electroweak monopoles with a non-linearly realized weak hypercharge by De Fabritiis, P., Helayël-Neto, J. A.

“…We present a finite-energy electroweak-monopole solution obtained by considering non-linear extensions of the hypercharge sector of the Electroweak Theory,…”
Get full text

Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections by Nosari, A.M., Caira, M., Pioltelli, M.L., Fanci, R., Bonini, A., Cattaneo, C., Castagnola, C., Capalbo, S.F., Fabritiis, P. De, Mettivier, V., Morselli, M., Pastore, D., Aversa, F., Rossi, G., Pagano, L.

“…The electronic surveillance system Hema e-Chart allowed us to prospectively collect data and to perform an analysis of invasive fungal infections (IFI)…”
Get full text

A prospective survey of febrile events in hematological malignancies by Pagano, L., Caira, M., Rossi, G., Tumbarello, M., Fanci, R., Garzia, M. G., Vianelli, N., Filardi, N., De Fabritiis, P., Beltrame, A., Musso, M., Piccin, A., Cuneo, A., Cattaneo, C., Aloisi, T., Riva, M., Rossi, G., Salvadori, U., Brugiatelli, M., Sannicolò, S., Morselli, M., Bonini, A., Viale, P., Nosari, A., Aversa, F.

“…The Hema e-Chart prospectively collected data on febrile events (FEs) in hematological malignancy patients (HMs). The aim of the study was to assess the…”
Get full text

Self-dual Maxwell-Chern-Simons solitons in a parity-invariant scenario by De Lima, W.B., De Fabritiis, P.

“…We present a self-dual parity-invariant U(1)×U(1) Maxwell-Chern-Simons scalar QED3. We show that the energy functional admits a Bogomol'nyi-type lower bound,…”
Get full text

Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network by Tendas, A, Cupelli, L, Mauroni, M R, Sollazzo, F, Di Piazza, F, Saltarelli, D, Carli, I, Chierichini, A, Melfa, C, Surano, M, Annibali, O, Piedimonte, M, Conte, E, Marchesi, F, Viggiani, C, Pignatelli, A C, Dentamaro, T, Niscola, P, de Fabritiis, P, Perrotti, A P, Arcese, W

Get full text

Lorentz-symmetry violation in the electroweak sector: Scattering processes in future e+ e− colliders by De Fabritiis, P., Malta, P.C., Neves, M.J.

“…We study CPT-odd non-minimal Lorentz-symmetry violating couplings in the electroweak sector modifying the interactions between leptons, gauge mediators and the…”
Get full text

Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies by Niscola, P, Romani, C, Scaramucci, L, Dentamaro, T, Cupelli, L, Tendas, A, Piccioni, D, Giovannini, M, Tolu, B, Cartoni, C, Arcuri, E, Perrotti, A, Palumbo, R, de Fabritiis, P

“…Severe pain syndromes may be recorded during all phases of haematopoietic stem cell transplantation (HSCT) for haematological malignancies: from stem cell…”
Get full text

Optimizing Umbilical Cord Blood Collection: Impact of Obstetric Factors Versus Quality of Cord Blood Units by Mancinelli, F., Tamburini, A., Spagnoli, A., Malerba, C., Suppo, G., Lasorella, R., de Fabritiis, P., Calugi, A.

“…The main limitation factor for wide use of umbilical cord blood units (UCBs) as a source of hematopoietic progenitors for transplantation is cell dose…”
Get full text

Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation by Busca, A., De Fabritiis, P., Ghisetti, V., Allice, T., Mirabile, M., Gentile, G., Locatelli, F., Falda, M.

“…: Antiviral compounds including ganciclovir, foscarnet, and cidofovir are routinely used in the treatment of cytomegalovirus (CMV) infection and disease;…”
Get full text

High-dose therapy with autologous PBSC transplantation in the front-line treatment of Waldenstrom's macroglobulinemia by Caravita, T, Siniscalchi, A, Tendas, A, Cupelli, L, Dentamaro, T, Natale, G, Spagnoli, A, de Fabritiis, P

Get full text

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation by VENDITTI, A, MAURILLO, L, PICARDI, A, FRANCHI, A, COCO, F. L, AMADORI, S, BUCCISANO, F, DEL POETA, G, MAZZONE, C, TAMBURINI, A, DEL PRINCIPE, M. I, CONSALVO, Ml, DE FABRITIIS, P, CUDILLO, L

“…A total of 31 adult patients with AML entered in the EORTC/GIMEMA AML-10 trial, who received autologous stem cell transplantation (ASCT) after induction and…”
Get full text

Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and or systemic fungal infection by DE FABRITIIS, P, SPAGNOLI, A, CUPELLI, L, CHIUSOLO, P, OLIVIERI, A, SANTARONE, S, POIDOMANI, M, FALLANI, S, NOVELLI, A, MAJOLINO, I, DI BARTOLOMEO, P, LOCASCIULLI, A, CUDILLO, L, MILONE, G, BUSCA, A, PICARDI, A, SCIME, R, BONINI, A

“…Transplanted patients with a history of invasive fungal infection (IFI) are at high risk of developing relapse and fatal complications. Eighteen patients…”
Get full text

High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome Transplant Network by Marchesi, F., Mengarelli, A., Giannotti, F., Tendas, A., Anaclerico, B., Porrini, R., Picardi, A., Cerchiara, E., Dentamaro, T., Chierichini, A., Romeo, A., Cudillo, L., Montefusco, E., Tirindelli, M.C., De Fabritiis, P., Annino, L., Petti, M.C., Monarca, B., Arcese, W., Avvisati, G.

“…The incidence of cytomegalovirus (CMV) reactivations in patients with multiple myeloma (MM) receiving autologous stem cell transplantation (ASCT) is relatively…”
Get full text

S113: NATIONAL PEGASPARGASE‐MODIFIED RISK‐ORIENTED PROGRAM FOR PHILADELPHIA‐NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (PH− ALL/LL). GIMEMA LAL 1913 FINAL RESULTS by Bassan, R., Chiaretti, S., Della Starza, I., Spinelli, O., Santoro, A., Elia, L., De Propris, M. S., Scattolin, A. M., Paoloni, F., Messina, M., Audisio, E., Marbello, L., Borlenghi, E., Zappasodi, P., Vetro, C., Martinelli, G., Mattei, D., Fracchiolla, N., Bocchia, M., De Fabritiis, P., Bonifacio, M., Candoni, A., Cassibba, V., Di Bartolomeo, P., Latte, G., Trappolini, S., Guarini, A., Vitale, A., Fazi, P., Vignetti, M., Rambaldi, A., Foà, R.

Get full text

274 SUCCESSFUL RE-TREATMENT WITH AZACITIDINE IN A PATIENT WITH MYELODYSPLASTIC SYNDROME (MDS) EVOLUTED INTO ACUTE MYELOID LEUKEMIA (AML) AFTER THE SUSPENSION OF THIS AGENT by Niscola, P, Tendas, A, Cupelli, L, Scaramucci, L, Giovannini, M, Fratoni, S, de Fabritiis, P

Get full text

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer: comment by Tendas, A., Scaramucci, L., Cupelli, L., Lentini, R., Trawinska, M. M., Giovannini, M., Perrotti, A., Fabritiis, P., Niscola, P.

Get full text

Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia by Del Poeta, G, Bruno, A, Del Principe, M I, Venditti, A, Maurillo, L, Buccisano, F, Stasi, R, Neri, B, Luciano, F, Siniscalchi, A, de Fabritiis, P, Amadori, S

“…Apoptosis plays a key role in the control of rapidly renewing tissues, such as the hematopoietic system and leukemia cells invariably have abnormalities in one…”
Get more information

Long-term neuropsychological deficits after cerebellar infarctions in two young adult twins by Fabbro, F., Tavano, A., Corti, S., Bresolin, N., De Fabritiis, P., Borgatti, R.

“…Two young adult dizygotic twins with high schooling suffered two strokes at the ages of 26 and 30 years. On the first occasion, Case 2 suffered a stroke only a…”
Get full text

Accidental falls in home care hematological patients by Tendas, A., Cupelli, L., Trawinska, M. M., Lentini, L., Giovannini, M., Scaramucci, L., Palombi, M., Brunetti, G. A., Cartoni, C., de Fabritiis, P., Niscola, P., Mandelli, F.

Get full text

Lenalidomide cutaneous adverse event: a case of Stevens–Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone by Siniscalchi, A., Tendas, A., Morino, L., Dentamaro, T., De Bellis, A., Perrotti, A., de Fabritiis, P., Musto, P., Caravita, T.

“…Stevens-Johnson syndrome (SJS) is a potentially deadly skin disease that usually results from a drug reaction. Typically, it involves the skin and mucous…”
Get full text